December 2, 2024
TOPLINE: A link between hepatic fat and intrapancreatic fat deposition (IPFD) in young and middle-aged adults without obesity and with low lipids and blood sugar seems […]
December 2, 2024
TOPLINE: Individuals with normal body mass index (BMI) measurements may still face an increased risk for colorectal cancer (CRC) if they have central obesity, characterized by […]
November 27, 2024
The holiday season is upon us, and for many people, meat is the centerpiece of celebratory meals. But eating less of it may do more when […]
November 27, 2024
(Reuters) – Canada’s health regulator has approved Novo Nordisk’s weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some […]
November 27, 2024
About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, said authors of a […]
November 27, 2024
About a third of people eligible for glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications for weight loss via the products’ labels would have been excluded […]
November 27, 2024
TOPLINE: In young adults with overweight, inulin-propionate ester (IPE), a novel food ingredient that aims to mimic the beneficial role of dietary fiber by boosting production […]
November 26, 2024
(Reuters) -Amgen’s experimental drug MariTide helped overweight or obese patients lose up to 20% weight on average in a year-long mid-stage trial, data that missed lofty […]
November 26, 2024
(Reuters) -Amgen’s experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage trial, but the results failed […]